Remisor Tab 100mg (20 Tablet / Pack)
A specialized oral mucosal protective and anti-ulcer tablet indicated for gastric ulcers and acute or chronic gastritis.
Remisor Tab (100mg) contains Rebamipide, a quinolinone derivative and gastroprotective agent engineered for the treatment of gastric ulcers and acute mucosal lesions. Operating as an endogenous prostaglandin inducer, it dramatically increases prostaglandin $E_2$ ($PGE_2$) levels in the gastric mucosa, stimulates thick gastric mucus secretion, clears toxic oxygen free radicals, and enhances regional microcirculation to accelerate the natural healing of gastric erosion, bleeding, redness, and edema.
Purpose
Enhances mucosal defense mechanisms by stimulating endogenous gastric prostaglandin synthesis, increasing mucus secretion, and improving microcirculation.
Ingredients
Rebamipide 100mg
Warnings
Administer the tablet strictly three times daily, preferably in the morning, evening, and immediately before bedtime. The safety of this compound in children has not been clinically established; restrict utilization strictly to adult populations. Carefully evaluate ongoing use in elderly patients, as they present with higher baseline baseline risks of hepatic or digestive sensitivities. Can be taken independently of food, though maintaining a consistent daily timeline optimizes the protective stabilization of the stomach lining.
Side Effects
Mild gastrointestinal adjustments including transient constipation, low-grade abdominal bloating, or temporary diarrhea. Potential for localized dermatological hypersensitivity reactions, such as mild skin rash, itching, or superficial eczema. Rare endocrine variations including menstrual cycle irregularities or transient gynecomastia in male patients. Occasional mild adjustments in daily taste perception, localized heartburn, or low-grade morning nausea.
Storage Instructions
Store safely below 30°C in a dry place, ensuring the tablets remain protected within their original blister packaging.
| Status | Active |